Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites.

PubWeight™: 2.08‹?› | Rank: Top 2%

🔗 View Article (PMID 16496326)

Published in Hepatology on March 01, 2006


Aftab Ala1, Carmen M Stanca, Moueen Bu-Ghanim, Imad Ahmado, Andrea D Branch, Thomas D Schiano, Joseph A Odin, Nancy Bach

Author Affiliations

1: Mount Sinai School of Medicine, New York, NY 10029, USA.

Articles citing this

A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. J Neurosurg Anesthesiol (2009) 3.30

Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg (2011) 3.08

Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30

The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56

Primary biliary cirrhosis. Semin Immunopathol (2009) 1.46

The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun (2007) 1.36

Primary biliary cirrhosis. Orphanet J Rare Dis (2008) 1.31

Pathogenesis of primary biliary cirrhosis. Gut (2007) 1.05

The diagnosis of primary biliary cirrhosis. Autoimmun Rev (2014) 1.03

Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. Hepat Mon (2011) 1.02

Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol (2009) 1.01

Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun (2013) 0.95

Clusters of spatial, temporal, and space-time distribution of hemorrhagic fever with renal syndrome in Liaoning Province, Northeastern China. BMC Infect Dis (2011) 0.95

The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol (2010) 0.93

Spatial proximity and the risk of psychopathology after a terrorist attack. Psychiatry Res (2010) 0.90

Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol Med (2012) 0.88

Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol (2010) 0.86

Clinical features and management of primary biliary cirrhosis. World J Gastroenterol (2008) 0.85

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol (2011) 0.85

Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. Am J Gastroenterol (2009) 0.83

Questionnaire based assessment of risk factors for primary biliary cirrhosis. Dig Liver Dis (2013) 0.82

Impact of microbes on autoimmune diseases. Arch Immunol Ther Exp (Warsz) (2013) 0.80

Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther (2015) 0.78

Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.78

Environmental factors in primary biliary cirrhosis. Semin Liver Dis (2014) 0.78

Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Dig Dis Sci (2017) 0.77

Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates. BMC Gastroenterol (2012) 0.77

Environmental xenoestrogens super-activate a variant murine ER beta in cholangiocytes. Toxicol Sci (2016) 0.76

Xenobiotics and loss of tolerance in primary biliary cholangitis. World J Gastroenterol (2016) 0.76

The Fingerprint of Antimitochondrial Antibodies and the Etiology of Primary Biliary Cholangitis. Hepatology (2017) 0.75

Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. J Clin Exp Hepatol (2016) 0.75

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort. Hepat Mon (2016) 0.75

Polluting the pathogenesis of primary biliary cirrhosis. Hepatology (2006) 0.75

Primary biliary cirrhosis and liver transplantation. Intractable Rare Dis Res (2012) 0.75

Toxicogenomic analysis reveals profibrogenic effects of trichloroethylene in autoimmune-mediated cholangitis in mice. Toxicol Sci (2014) 0.75

Hazardous waste and health impact: a systematic review of the scientific literature. Environ Health (2017) 0.75

Articles by these authors

Rare birds in North America: acute hepatitis C cohorts. Gastroenterology (2008) 3.45

Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64

A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol (2004) 2.36

Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.21

Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol (2004) 2.12

TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol (2015) 1.99

Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78

Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol (2006) 1.69

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68

Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A (2007) 1.64

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet (2010) 1.62

Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant (2003) 1.60

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res (2004) 1.57

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32

Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis (2008) 1.18

The quasispecies nature and biological implications of the hepatitis C virus. Infect Genet Evol (2009) 1.14

Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA (2002) 1.13

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13

Restricted use of albumin for spontaneous bacterial peritonitis. Gut (2007) 1.10

Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses (2010) 1.08

Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol (2008) 1.08

Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08

Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis (2008) 1.08

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05

T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03

Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01

Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J Virol (2009) 1.01

Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol (2009) 1.01

Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co-expressing HCV core protein and CYP2E1. J Med Virol (2004) 0.99

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res (2009) 0.99

Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2007) 0.98

Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology (2004) 0.97

Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology (2004) 0.95

Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol (2002) 0.95

Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94

Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis (2011) 0.94

Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization. Obes Surg (2009) 0.93

Toll-like receptors and liver disease. Liver Int (2013) 0.92

Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91

Pathogenic role of environmental toxins in immune-mediated liver diseases. J Immunotoxicol (2008) 0.91

Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis (2013) 0.90

Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics (2011) 0.90

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun (2007) 0.90

Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol (2014) 0.89

Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol (2005) 0.89

Vitamin D for your patients with chronic hepatitis C? J Hepatol (2012) 0.89

Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. J Oral Maxillofac Surg (2010) 0.88

Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis (2012) 0.88

Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature. Semin Liver Dis (2005) 0.87

Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87

Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl (2014) 0.87

Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis (2007) 0.87

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl (2006) 0.87

The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem J (2002) 0.85

Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci (2013) 0.84

Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant (2012) 0.84

Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis (2005) 0.84

Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis (2008) 0.84

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis (2013) 0.84

Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83

Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery (2013) 0.83

Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. J Crohns Colitis (2012) 0.83

Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. J Hepatol (2011) 0.82

Results of retransplantation for recurrent hepatitis C. Hepatology (2003) 0.82

Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy. J Int Assoc Provid AIDS Care (2013) 0.82

The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82

Overdose with suicidal intent: ethical considerations for liver transplant programs. Liver Transpl (2011) 0.82

Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82

Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis (2012) 0.82

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients. J Hepatol (2010) 0.82

HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core gene. Semin Liver Dis (2011) 0.82

Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol (2007) 0.82

Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation (2015) 0.82

Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant (2004) 0.81

Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol (2002) 0.81

Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol (2012) 0.81

Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci (2008) 0.80

Outcome of patients with regadenoson-induced ST-segment depression but normal perfusion on single-photon emission computed tomography. Angiology (2012) 0.80

Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun Rev (2003) 0.80

Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation (2007) 0.79

Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol Int (2010) 0.78

Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl (2007) 0.78

Adult live donor liver transplantation. Clin Liver Dis (2005) 0.78

An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78